Strong HPV Vaccine Response Predicts Better Survival with Chemotherapy
- PMID: 32220926
- DOI: 10.1158/2159-8290.CD-RW2020-046
Strong HPV Vaccine Response Predicts Better Survival with Chemotherapy
Abstract
Patients with HPV16+ cervical cancer and high T-cell responses to an HPV16 vaccine survived longer.
©2020 American Association for Cancer Research.
Comment on
-
Strong vaccine responses during chemotherapy are associated with prolonged cancer survival.Sci Transl Med. 2020 Mar 18;12(535):eaaz8235. doi: 10.1126/scitranslmed.aaz8235. Sci Transl Med. 2020. PMID: 32188726
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
